These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37334759)

  • 61. [Generalized non-bacterial exanthematous pustulosis or generalized pustular psoriasis in children. Two case-reports (author's transl)].
    Massicot P; Mollard S; Guillet G; Cadier L; Renouil M; Maleville J
    Ann Pediatr (Paris); 1982 Jan; 29(1):60-3. PubMed ID: 7055359
    [No Abstract]   [Full Text] [Related]  

  • 62. Efficacy and safety of bimekizumab for the treatment of psoriasis: a systematic review and meta-analysis of randomized clinical trials.
    Qiu Y; Zhu Y; Liu Y; Liu Q
    J Dermatolog Treat; 2023 Dec; 34(1):2199106. PubMed ID: 37010492
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis: Pooled Results From Phase 2 and Phase 3 Randomized Clinical Trials.
    Gordon KB; Langley RG; Warren RB; Okubo Y; Stein Gold L; Merola JF; Peterson L; Wixted K; Cross N; Deherder D; Thaçi D
    JAMA Dermatol; 2022 Jul; 158(7):735-744. PubMed ID: 35544084
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Paradoxical Pustular Psoriasis in a Patient With Psoriatic Arthritis on Secukinumab Treatment.
    Abbruzzese A; Venerito V; Lopalco G; Fornaro M; Giannotta M; Iannone F
    J Clin Rheumatol; 2020 Sep; 26(6):e208-e209. PubMed ID: 31192857
    [No Abstract]   [Full Text] [Related]  

  • 65. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients.
    Wollina U; Hansel G; Koch A; Schönlebe J; Köstler E; Haroske G
    Am J Clin Dermatol; 2008; 9(1):1-14. PubMed ID: 18092839
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Infantile generalized pustular psoriasis with excellent response to secukinumab: A case report.
    Guevara BEK; Aquino JMRM; Diaz RBS; Contreras AIT; Jeng YC; Huang HY; Hsu CK; Pandita-Reyes BSB
    Exp Dermatol; 2023 Aug; 32(8):1296-1298. PubMed ID: 36847294
    [No Abstract]   [Full Text] [Related]  

  • 67. Generalized pustular psoriasis: a review and update on treatment.
    Hoegler KM; John AM; Handler MZ; Schwartz RA
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1645-1651. PubMed ID: 29573491
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Successful treatment of a 3-year-old girl with generalized pustular psoriasis using secukinumab monotherapy.
    Zhu H; Song P; Du D; Tian H
    Pediatr Dermatol; 2021 Sep; 38(5):1366-1367. PubMed ID: 34515373
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy and safety of secukinumab in moderate to severe palmoplantar pustular psoriasis over 148 weeks: Extension of the 2PRECISE study.
    Mrowietz U; Bachelez H; Burden AD; Rissler M; Sieder C; Orsenigo R; Jagiello P
    J Am Acad Dermatol; 2021 Feb; 84(2):552-554. PubMed ID: 32565211
    [No Abstract]   [Full Text] [Related]  

  • 70. Successful treatment of generalized pustular psoriasis with secukinumab: a report of two cases.
    Sun ZL; Liu ZL; Xu YY; Zhang XL; Zhang CL; Guan X
    Chin Med J (Engl); 2020 Nov; 133(24):3015-3016. PubMed ID: 33237694
    [No Abstract]   [Full Text] [Related]  

  • 71. Rapid response of generalized pustular psoriasis to treatment with risankizumab. A therapeutic option for a difficult-to-treat disease.
    May Lee M; Fantini C; Mori E; Feliciani C; Satolli F
    Ital J Dermatol Venerol; 2023 Aug; 158(4):377-378. PubMed ID: 37198888
    [No Abstract]   [Full Text] [Related]  

  • 72. Successful Treatment of Recurrent Pustular Psoriasis of Pregnancy with Secukinumab: A Case Report.
    Liu N; Zhu L; Cheng Y; Yu N; Yi X; Ding Y
    Acta Derm Venereol; 2020 Aug; 100(15):adv00251. PubMed ID: 32812054
    [No Abstract]   [Full Text] [Related]  

  • 73. Successful secukinumab treatment of recalcitrant juvenile generalized pustular psoriasis.
    Nishida M; Takeichi T; Kono M; Imanishi A; Maekawa N; Akiyama M; Fukai K
    J Dermatol; 2020 Mar; 47(3):e77-e78. PubMed ID: 31907962
    [No Abstract]   [Full Text] [Related]  

  • 74. Pembrolizumab-induced psoriasis vulgaris successfully treated with apremilast.
    Takama H; Shibata T; Ando Y; Yanagishita T; Ohshima Y; Akiyama M; Watanabe D
    Eur J Dermatol; 2020 Apr; 30(2):188-190. PubMed ID: 32538362
    [No Abstract]   [Full Text] [Related]  

  • 75. Recalcitrant pustular psoriasis successfully treated with adalimumab.
    Alvarez AC; Rodríguez-Nevado I; De Argila D; Rubio FP; Rovira I; Torrelo A; Zambrano A
    Pediatr Dermatol; 2011; 28(2):195-7. PubMed ID: 21504452
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Successful use of lymphoplasma exchange in a patient with acute generalized pustular psoriasis of von Zumbusch.
    Zhang M; Zhang Y; Zhu W; Kuang Y
    Dermatol Ther; 2020 Nov; 33(6):e14092. PubMed ID: 32720411
    [No Abstract]   [Full Text] [Related]  

  • 77. Infant case of generalized pustular psoriasis preceded by interstitial lung disease.
    Noguchi N; Sato T; Adachi H; Nagai T; Tomura Y; Toyoshima A; Takahashi T; Manabe M; Osada SI
    J Dermatol; 2020 Sep; 47(9):e322-e324. PubMed ID: 32594579
    [No Abstract]   [Full Text] [Related]  

  • 78. Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study.
    Elewski BE; Lebwohl MG; Anadkat MJ; Barker J; Ghoreschi K; Imafuku S; Mrowietz U; Li L; Quaresma M; Thoma C; Bachelez H
    J Am Acad Dermatol; 2023 Jul; 89(1):36-44. PubMed ID: 36870370
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reactivation of pustular psoriasis following mRNA vaccination versus COVID-19 infection: An overlap?: Reply to "Generalized pustular psoriasis following COVID-19" by Dadras MS et al.: Reply to "Generalized pustular psoriasis following COVID-19" by Dadras MS et al.
    Almeida RO; Hanemann T; Peres FLX; Escobar GF; Rangel Bonamigo R
    Dermatol Ther; 2022 Dec; 35(12):e15892. PubMed ID: 36193726
    [No Abstract]   [Full Text] [Related]  

  • 80. Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J).
    Saeki H; Nakagawa H; Nakajo K; Ishii T; Morisaki Y; Aoki T; Cameron GS; Osuntokun OO;
    J Dermatol; 2017 Apr; 44(4):355-362. PubMed ID: 27726163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.